# Trial To Assess Efficacy Of A Chimeric Skin In Patients With Epidermolysys Bullosa

> **NCT00987142** · PHASE2 · COMPLETED · sponsor: **Tigenix S.A.U.** · enrollment: 12 (actual)

## Conditions studied

- EPIDERMOLYSIS BULLOSA

## Interventions

- **DRUG:** CX501
- **DEVICE:** Occlusive non adherent dressing

## Key facts

- **NCT ID:** NCT00987142
- **Lead sponsor:** Tigenix S.A.U.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2019-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00987142

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00987142, "Trial To Assess Efficacy Of A Chimeric Skin In Patients With Epidermolysys Bullosa". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00987142. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*